Maribavir

From IDWiki

Revision as of 00:21, 13 March 2020 by Aidan (talk | contribs) (Created page with "* Class is benzimidazole riboside * Mechanism of action is inhibition of UL97-mediated phosphorylation of nuclear lamin A/C * Main indication is CMV prophylaxis in solid-o...")

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to:navigation, search

Class is benzimidazole riboside
Mechanism of action is inhibition of UL97-mediated phosphorylation of nuclear lamin A/C
Main indication is CMV prophylaxis in solid-organ transplant

Further Reading

Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study. Clin Infect Dis. 2019;68(8):1255–1264. DOI: 10.1093/cid/ciy706

Retrieved from "https://idwiki.org/index.php?title=Maribavir&oldid=3732"

Antivirals